Table 1.
Baseline demographic statistics for DDLT and LDLT recipients.
| Variables |
DDLT (n = 19582) |
LDLT (n = 902) |
P value |
|---|---|---|---|
| Recipient age, n (%) | |||
| ≤50 | 6652 (34) | 386 (42.8) | <0.0001 |
| >50 | 12930 (66) | 516 (57.2) | |
| Recipient gender, n (%) | |||
| Female | 6350 (32.4) | 405 (44.9) | <0.0001 |
| Male | 13232 (67.6) | 497 (55.1) | |
| Recipient race, n (%) | |||
| Caucasian | 14377 (73.4) | 761 (84.4) | <0.0001 |
| African American | 1784 (9.1) | 32 (3.5) | |
| Hispanic | 2320 (11.8) | 76 (8.4) | |
| Others | 1101 (5.6) | 33 (3.7) | |
| Recipient BMI, n (%) | |||
| ≤25 | 6154 (32.9) | 396 (45.7) | <0.0001 |
| 25–30 | 6800 (36.3) | 299 (34.5) | |
| >30 | 5761 (30.8) | 171 (19.7) | |
| Etiology of liver disease, n (%) | |||
| ALD | 2481 (12.7) | 78 (8.6) | <0.0001 |
| ALF | 1070 (5.5) | 24 (2.7) | |
| HCV | 9837 (50.2) | 324 (35.9) | |
| NASH | 646 (3.3) | 17 (1.9) | |
| Others | 5548 (28.3) | 59 (50.9) | |
| MELD score | |||
| Mean (SD) | 20.9 (9.8) | 14.6 (5.3) | <0.0001 |
| Donor age, n (%) | |||
| <40 | 8754 (44.7) | 508 (56.4) | <0.0001 |
| 40–60 | 7926 (39.5) | 380 (42.3) | |
| ≥61 | 3102 (15.8) | 13 (1.4) | |
| Donor gender, n (%) | |||
| Female | 7876 (40.2) | 446 (49.4) | <0.0001 |
| Male | 11706 (59.8) | 456 (50.6) | |
| Donor race, n (%) | |||
| Caucasian | 13304 (67.9) | 766 (84.9) | <0.0001 |
| African American | 3094 (15.8) | 26 (2.9) | |
| Hispanic | 2567 (13.1) | 81 (9) | |
| Others | 617 (3.2) | 29 (3.2) | |
| Cold ischemia time, n (%) | |||
| <6 h | 6385 (32.6) | 658 (93.2) | <0.0001 |
| 6–12 h | 11105 (56.7) | 12 (1.7) | |
| >12 h | 839 (4.6) | 36 (5.1) | |
| Episode of rejection, n (%) | |||
| Yes (with treatment) | 967 (4.9) | 33 (3.7) | 0.1267 |
| Yes (no treatment) | 250 (1.3) | 9 (1) | |
| No | 17265 (88.2) | 807 (89.4) | |
| Missing | 1100 (5.6) | 53 (5.9) | |
| Steroid induction, n (%) | |||
| Yes | 10780 (55) | 650 (72) | <0.0001 |
| No | 7141 (36.5) | 227 (25.2) | |
| Missing | 1661 (8.5) | 25 (2.8) | |
| Calcineurin inhibitor use, n (%) | |||
| Yes | 18806 (96) | 881 (97.7) | 0.0159 |
| No | 776 (4) | 21 (2.3) | |
| Patient survival time (days) | |||
| Mean (SD) | 954.5 (608.5) | 1082.5 (642.6) | <0.0001 |
DDLT: deceased donor liver transplant; LDLT: living donor liver transplant; BMI: body mass index; ALD: alcohol liver disease; ALF: acute liver failure; HCV: hepatitis C virus; NASH: nonalcoholic steatohepatitis; MELD: model for end-stage liver disease.